{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:47:48Z","timestamp":1785257268251,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01616-3","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T11:09:51Z","timestamp":1731755391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort"],"prefix":"10.1186","volume":"16","author":[{"given":"Luis","family":"Castilla-Mart\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mait\u00e9e","family":"Rosende-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Tartari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Casales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Nelet","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natali","family":"Bein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Alegret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"P\u00e9rez-Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Blazquez-Folch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"de Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e0udia","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Mu\u00f1oz-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bay\u00f3n-Buj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"T\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Castilla-Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"1616_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision. Arlington: American Psychiatric Publishing; 2022. ISBN: 978\u20130890425756. Diagnostic and Statistical Manual of Mental Disorders. 2022.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"1616_CR2","doi-asserted-by":"crossref","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007 [cited 2024 Sep 8];69:2197\u2013204. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17568013\/.","DOI":"10.1212\/01.wnl.0000271090.28148.24"},{"key":"1616_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13195-015-0104-7","volume":"7","author":"HC Chui","year":"2015","unstructured":"Chui HC, Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther. 2015;7:21.","journal-title":"Alzheimers Res Ther"},{"key":"1616_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia. 2011;7:263\u20139.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"1616_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS\u2013ADRDA criteria. Lancet Neurol. 2007;6:734\u201346.","journal-title":"Lancet Neurol"},{"key":"1616_CR6","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 [cited 2024 Jul 2];43:250\u201360. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8094895\/.","DOI":"10.1212\/WNL.43.2.250"},{"key":"1616_CR7","doi-asserted-by":"crossref","unstructured":"Wang J, Jin C, Zhou J, Zhou R, Tian M, Lee HJ, et al. PET molecular imaging for pathophysiological visualization in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2023 [cited 2024 Sep 13];50:765\u201383. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36372804\/.","DOI":"10.1007\/s00259-022-05999-z"},{"key":"1616_CR8","doi-asserted-by":"crossref","unstructured":"Hazan J, Wing M, Liu KY, Reeves S, Howard R. Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2023 [cited 2024 Sep 13];94:113\u201320. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36096664\/.","DOI":"10.1136\/jnnp-2022-329530"},{"key":"1616_CR9","doi-asserted-by":"crossref","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain - From eye research to CNS disorders. Nat Rev Neurol. 2013. p. 44\u201353.","DOI":"10.1038\/nrneurol.2012.227"},{"key":"1616_CR10","doi-asserted-by":"crossref","unstructured":"Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004 [cited 2024 Sep 8];137:156\u201369. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/14700659\/.","DOI":"10.1016\/S0002-9394(03)00792-X"},{"key":"1616_CR11","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.2.6","author":"SK Wagner","year":"2020","unstructured":"Wagner SK, Fu DJ, Faes L, Liu X, Huemer J, Khalid H, Insights into Systemic Disease through Retinal Imaging-Based Oculomics. Transl Vis Sci Technol., et al. [cited 2024 Sep 1];9:6\u20136. Available from: 2020. https:\/\/doi.org\/10.1167\/tvst.9.2.6.","journal-title":"Available from:"},{"key":"1616_CR12","doi-asserted-by":"crossref","unstructured":"Patterson EJ, Bounds AD, Wagner SK, Kadri-Langford R, Taylor R, Daly D. Oculomics: A Crusade Against the Four Horsemen of Chronic Disease. Ophthalmol Ther. 2024 [cited 2024 Sep 8];13:1427\u201351. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38630354\/.","DOI":"10.1007\/s40123-024-00942-x"},{"key":"1616_CR13","doi-asserted-by":"crossref","unstructured":"Wagner SK, Hughes F, Cortina-Borja M, Pontikos N, Struyven R, Liu X, et al. AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK. BMJ Open. 2022 [cited 2024 Sep 1];12:e058552. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35296488\/.","DOI":"10.1136\/bmjopen-2021-058552"},{"key":"1616_CR14","doi-asserted-by":"publisher","first-page":"16345","DOI":"10.1038\/s41598-018-34577-3","volume":"8","author":"D S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez D, Castilla-Marti M, Rodr\u00edguez-G\u00f3mez O, Valero S, Piferrer A, Mart\u00ednez G, et al. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer\u2019s disease. Sci Rep. 2018;8:16345.","journal-title":"Sci Rep"},{"key":"1616_CR15","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.12977","volume":"94","author":"E Garcia-Martin","year":"2016","unstructured":"Garcia-Martin E, Bambo MP, Marques ML, Satue M, Otin S, Larrosa JM, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer\u2019s disease. Acta Ophthalmol. 2016;94:e454\u20139.","journal-title":"Acta Ophthalmol"},{"key":"1616_CR16","doi-asserted-by":"crossref","unstructured":"Cheung CY-L, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, et al. Retinal Ganglion Cell Analysis Using High-Definition Optical Coherence Tomography in Patients with Mild Cognitive Impairment and Alzheimer\u2019s Disease. J Alzheimers Dis. 2014.","DOI":"10.3233\/JAD-141659"},{"key":"1616_CR17","doi-asserted-by":"crossref","unstructured":"Cunha LP, Lopes LC, Costa-Cunha LVF, Costa CF, Pires LA, Almeida ALM, et al. Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer\u02bcs Disease. Mori K, editor. PLoS One. 2016;11:e0153830.","DOI":"10.1371\/journal.pone.0153830"},{"key":"1616_CR18","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41598-020-58399-4","volume":"10","author":"D S\u00e1nchez","year":"2020","unstructured":"S\u00e1nchez D, Castilla-Marti M, Marqui\u00e9 M, Valero S, Moreno-Grau S, Rodr\u00edguez-G\u00f3mez O, et al. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer\u2019s disease in a memory clinic. Sci Rep. 2020;10:1580.","journal-title":"Sci Rep"},{"key":"1616_CR19","doi-asserted-by":"crossref","unstructured":"Schrijvers EMC, Buitendijk GHS, Ikram MK, Koudstaal PJ, Hofman A, Vingerling JR, et al. Retinopathy and risk of dementia: The Rotterdam Study. Neurology. 2012 [cited 2024 Sep 1];79:365. Available from: \/pmc\/articles\/PMC3400091\/.","DOI":"10.1212\/WNL.0b013e318260cd7e"},{"key":"1616_CR20","doi-asserted-by":"crossref","unstructured":"Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, et al. Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: What we know, what we don\u2019t, and how to move forward. Alzheimer\u2019s and Dementia. John Wiley and Sons Inc.; 2020. p. 229\u201343.","DOI":"10.1002\/alz.12006"},{"key":"1616_CR21","doi-asserted-by":"crossref","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke; a journal of cerebral circulation. 2011 [cited 2024 Jul 2];42:2672. Available from: \/pmc\/articles\/PMC3778669\/.","DOI":"10.1161\/STR.0b013e3182299496"},{"key":"1616_CR22","doi-asserted-by":"crossref","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024 [cited 2024 Sep 5];404:572\u2013628. Available from: http:\/\/www.thelancet.com\/article\/S0140673624012960\/fulltext.","DOI":"10.1016\/S0140-6736(24)01296-0"},{"key":"1616_CR23","first-page":"775","volume":"11","author":"S Asanad","year":"2019","unstructured":"Asanad S, Ross-Cisneros FN, Barron E, Nassisi M, Sultan W, Karanjia R, et al. The retinal choroid as an oculovascular biomarker for Alzheimer\u2019s dementia: A histopathological study in severe disease. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2019;11:775\u201383.","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"1616_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ophtha.2018.10.001","volume":"126","author":"AA Sadun","year":"2019","unstructured":"Sadun AA, Asanad S. The Eye in Alzheimer\u2019s Disease. Ophthalmology. 2019;126:511\u20132.","journal-title":"Ophthalmology"},{"key":"1616_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2898704","volume":"2016","author":"M Bulut","year":"2016","unstructured":"Bulut M, Yaman A, Erol MK, Kurtulu\u015f F, Toslak D, Do\u011fan B, et al. Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer\u2019s Type Dementia. J Ophthalmol. 2016;2016:1\u20137.","journal-title":"J Ophthalmol"},{"key":"1616_CR26","doi-asserted-by":"crossref","unstructured":"Li M, Li R, Lyu JH, Chen JH, Wang W, Gao ML, et al. Relationship Between Alzheimer\u2019s Disease and Retinal Choroidal Thickness: A Cross-Sectional Study. J Alzheimers Dis. 2021 [cited 2024 Jul 22];80:407\u201319. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33554907\/.","DOI":"10.3233\/JAD-201142"},{"key":"1616_CR27","first-page":"11","volume":"8","author":"JP Cunha","year":"2017","unstructured":"Cunha JP, Proen\u00e7a R, Dias-Santos A, Melancia D, Almeida R, \u00c1guas H, et al. Choroidal thinning: Alzheimer\u2019s disease and aging. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;8:11\u20137.","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"1616_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13195-020-00602-9","volume":"12","author":"M Marqui\u00e9","year":"2020","unstructured":"Marqui\u00e9 M, Valero S, Castilla-Marti M, Mart\u00ednez J, Rodr\u00edguez-G\u00f3mez O, Sanabria \u00c1, et al. Association between retinal thickness and \u03b2-amyloid brain accumulation in individuals with subjective cognitive decline: Fundaci\u00f3 ACE Healthy Brain Initiative. Alzheimers Res Ther. 2020;12:37.","journal-title":"Alzheimers Res Ther"},{"key":"1616_CR29","doi-asserted-by":"publisher","first-page":"16938","DOI":"10.1038\/s41598-022-21558-w","volume":"12","author":"M Marqui\u00e9","year":"2022","unstructured":"Marqui\u00e9 M, Valero S, Mart\u00ednez J, Alarc\u00f3n-Mart\u00edn E, Garc\u00eda-S\u00e1nchez A, de Rojas I, et al. Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort. Sci Rep. 2022;12:16938.","journal-title":"Sci Rep"},{"key":"1616_CR30","unstructured":"Garc\u00eda-S\u00e1nchez A, Sotolongo-Grau O, Tartari JP, Sanabria \u00c1, Esteban - De Antonio E, P\u00e9rez-Cord\u00f3n A, et al. Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort. Alzheimers Res Ther. 2024 [cited 2024 Jul 2];16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38378643\/."},{"key":"1616_CR31","doi-asserted-by":"crossref","unstructured":"Boada M, T\u00e1rraga L, Hern\u00e1ndez I, Valero S, Alegret M, Ruiz A, et al. Design of a comprehensive Alzheimer\u2019s disease clinic and research center in Spain to meet critical patient and family needs. Alzheimers Dement. 2014 [cited 2014 Dec 30];10:409\u201315. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24035148.","DOI":"10.1016\/j.jalz.2013.03.006"},{"key":"1616_CR32","doi-asserted-by":"crossref","unstructured":"Abdelnour C, Rodr\u00edguez-G\u00f3mez O, Alegret M, Valero S, Moreno-Grau S, Sanabria \u00c1, et al. Impact of Recruitment Methods in Subjective Cognitive Decline. Gifford K, editor. Journal of Alzheimer\u2019s Disease. 2017;57:625\u201332.","DOI":"10.3233\/JAD-160915"},{"key":"1616_CR33","unstructured":"Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, et al. FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols. J Prev Alzheimers Dis. 2017 [cited 2020 Aug 8];4:100\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29186280\/."},{"key":"1616_CR34","doi-asserted-by":"crossref","unstructured":"Esteban De Antonio E, P\u00e9rez-Cord\u00f3n A, Gil S, Orellana A, Cano A, Alegret M, et al. BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols. J Alzheimers Dis. 2021 [cited 2024 Sep 8];83:1233\u201349. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34420953\/.","DOI":"10.3233\/JAD-210254"},{"key":"1616_CR35","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136\u20139.","journal-title":"Am J Psychiatry"},{"key":"1616_CR36","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"1616_CR37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S0028-3932(01)00055-0","volume":"39","author":"R Blesa","year":"2001","unstructured":"Blesa R, Pujol M, Aguilar M, Santacruz P, Bertran-Serra I, Hern\u00e1ndez G, et al. Clinical validity of the \u201cmini-mental state\u201d for Spanish speaking communities. Neuropsychologia. 2001;39:1150\u20137.","journal-title":"Neuropsychologia"},{"key":"1616_CR38","doi-asserted-by":"crossref","unstructured":"Del Ser Quijano T, S\u00e1nchez-S\u00e1nchez F, Garc\u00eda De Y\u00e9benes MJ, Otero A, Munoz DG. Validation of the seven-minute screen neurocognitive battery for the diagnosis of dementia in a Spanish population-based sample. Dement Geriatr Cogn Disord. 2006;22:454\u201364.","DOI":"10.1159\/000095858"},{"key":"1616_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1616_CR40","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR). Neurology. 1993;43:2412.","journal-title":"Neurology"},{"key":"1616_CR41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1192\/bjp.114.512.797","volume":"114","author":"G Blessed","year":"1968","unstructured":"Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797\u2013811.","journal-title":"Br J Psychiatry"},{"key":"1616_CR42","doi-asserted-by":"crossref","unstructured":"Alegret M, Espinosa A, Valero S, Vinyes-Junqu\u00e9 G, Ruiz A, Hern\u00e1ndez I, et al. Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old. Brucki S, editor. PLoS One. 2013;8:e76436.","DOI":"10.1371\/journal.pone.0076436"},{"key":"1616_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13803395.2011.630652","volume":"34","author":"M Alegret","year":"2012","unstructured":"Alegret M, Espinosa A, Vinyes-Junqu\u00e9 G, Valero S, Hern\u00e1ndez I, T\u00e1rraga L, et al. Normative data of a brief neuropsychological battery for Spanish individuals older than 49. J Clin Exp Neuropsychol. 2012;34:209\u201319.","journal-title":"J Clin Exp Neuropsychol"},{"key":"1616_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183\u201394.","journal-title":"J Intern Med"},{"key":"1616_CR45","doi-asserted-by":"publisher","unstructured":"Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al. Prevalence and Classification of Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study. Arch Neurol. 2003 [cited 2017 Apr 23];60:1385. Available from: https:\/\/doi.org\/10.1001\/archneur.60.10.1385.","DOI":"10.1001\/archneur.60.10.1385"},{"key":"1616_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JAD-122002","volume":"34","author":"A Espinosa","year":"2013","unstructured":"Espinosa A, Alegret M, Valero S, Vinyes-Junqu\u00e9 G, Hern\u00e1ndez I, Maule\u00f3n A, et al. A Longitudinal Follow-Up of 550 Mild Cognitive Impairment Patients: Evidence for Large Conversion to Dementia Rates and Detection of Major Risk Factors Involved. Journal of Alzheimer\u2019s Disease. 2013;34:769\u201380.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"1616_CR47","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia. 2014;10:844\u201352.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"1616_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00406-014-0539-z","volume":"264","author":"F Jessen","year":"2014","unstructured":"Jessen F. Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. 2014;264:3\u20137.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1616_CR49","doi-asserted-by":"crossref","unstructured":"Bokinni Y, Shah N, Maguire O, Laidlaw DAH. Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements. Eye (Lond). 2015 [cited 2024 Sep 9];29:1085\u201391. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26043703\/.","DOI":"10.1038\/eye.2015.94"},{"key":"1616_CR50","doi-asserted-by":"crossref","unstructured":"Chew EY, Lindblad AS, Clemons T. Summary results and recommendations from the age-related eye disease study. Archives of Ophthalmology. 2009 [cited 2020 Aug 8];127:1678\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3027407\/.","DOI":"10.1001\/archophthalmol.2009.312"},{"key":"1616_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/IJG.0b013e318133fb32","volume":"17","author":"N Pakrou","year":"2008","unstructured":"Pakrou N, Gray T, Mills R, Landers J, Craig J. Clinical Comparison of the Icare Tonometer and Goldmann Applanation Tonometry. J Glaucoma. 2008;17:43\u20137.","journal-title":"J Glaucoma"},{"key":"1616_CR52","doi-asserted-by":"publisher","unstructured":"Liu B, Wang Y, Li T, Lin Y, Ma W, Chen X, et al. Correlation of subfoveal choroidal thickness with axial length, refractive error, and age in adult highly myopic eyes. BMC Ophthalmol. 2018 [cited 2024 Oct 17];18:1\u20135. Available from: https:\/\/bmcophthalmol.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12886-018-0791-5.","DOI":"10.1186\/s12886-018-0791-5"},{"key":"1616_CR53","doi-asserted-by":"publisher","unstructured":"Zhang Z, Mu J, Wei J, Geng H, Liu C, Yi W, et al. Correlation between refractive errors and ocular biometric parameters in children and adolescents: a systematic review and meta-analysis. BMC Ophthalmology 2023 23:1. 2023 [cited 2024 Oct 17];23:1\u201324. Available from: https:\/\/bmcophthalmol.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12886-023-03222-7.","DOI":"10.1186\/s12886-023-03222-7"},{"key":"1616_CR54","unstructured":"Watch How It Works: Triton Swept-Source OCT - Topcon Healthcare. [cited 2024 Oct 13]. Available from: https:\/\/topconhealthcare.com\/article\/watch-how-it-works-triton-swept-source-oct\/."},{"key":"1616_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WAD.0000000000000176","volume":"31","author":"A Trebbastoni","year":"2017","unstructured":"Trebbastoni A, Marcelli M, Mallone F, D\u2019Antonio F, Imbriano L, Campanelli A, et al. Attenuation of Choroidal Thickness in Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord. 2017;31:128\u201334.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1616_CR56","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020. Available from: http:\/\/www.r-project.org\/index.html. [cited 2022 Aug 12]. Available from: https:\/\/www.eea.europa.eu\/data-and-maps\/indicators\/oxygen-consuming-substances-in-rivers\/r-development-core-team-2006."},{"key":"1616_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"key":"1616_CR58","doi-asserted-by":"crossref","unstructured":"Liljequist D, Elfving B, Skavberg Roaldsen K. Intraclass correlation \u2013 A discussion and demonstration of basic features. Chiacchio F, editor. PLoS One. 2019;14:e0219854.","DOI":"10.1371\/journal.pone.0219854"},{"key":"1616_CR59","doi-asserted-by":"crossref","unstructured":"Marqui\u00e9 M, Garc\u00eda-S\u00e1nchez A, Alarc\u00f3n-Mart\u00edn E, Mart\u00ednez J, Castilla-Mart\u00ed M, Castilla-Mart\u00ed L, et al. Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer\u2019s disease in individuals with mild cognitive impairment: The NORFACE cohort. Front Neurosci. 2023 [cited 2024 Jul 2];17. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36908784\/.","DOI":"10.3389\/fnins.2023.1076177"},{"key":"1616_CR60","doi-asserted-by":"crossref","unstructured":"Gharbiya M, Trebbastoni A, Parisi F, Manganiello S, Cruciani F, D\u2019Antonio F, et al. Choroidal Thinning as a New Finding in Alzheimer\u2019s Disease: Evidence from Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography. J Alzheimers Dis. 2014;40:907\u201317.","DOI":"10.3233\/JAD-132039"},{"key":"1616_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm10040231","volume":"10","author":"E Salobrar-Garcia","year":"2020","unstructured":"Salobrar-Garcia E, M\u00e9ndez-Hern\u00e1ndez C, de Hoz R, Ram\u00edrez AI, L\u00f3pez-Cuenca I, Fern\u00e1ndez-Albarral JA, et al. Ocular vascular changes in mild alzheimer\u2019s disease patients: Foveal avascular zone, choroidal thickness, and onh hemoglobin analysis. J Pers Med. 2020;10:1\u201313.","journal-title":"J Pers Med"},{"key":"1616_CR62","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-De-Eguileta A, Lage C, L\u00f3pez-Garc\u00eda S, Pozueta A, Garc\u00eda-Mart\u00ednez M, Kazimierczak M, et al. Evaluation of choroidal thickness in prodromal Alzheimer\u2019s disease defined by amyloid PET. PLoS One. 2020 [cited 2024 Jul 22];15. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32956392\/.","DOI":"10.1371\/journal.pone.0239484"},{"key":"1616_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ceo.12386","volume":"43","author":"HA Bayhan","year":"2015","unstructured":"Bayhan HA, Aslan Bayhan S, Celikbilek A, Tan\u0131k N, G\u00fcrdal C. Evaluation of the chorioretinal thickness changes in <scp>A<\/scp> lzheimer\u2019s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol. 2015;43:145\u201351.","journal-title":"Clin Exp Ophthalmol"},{"key":"1616_CR64","doi-asserted-by":"crossref","unstructured":"Sull AC, Vuong LN, Price LL, Srinivasan VJ, Gorczynska I, Fujimoto JG, et al. Comparison of spectral\/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina. 2010 [cited 2024 Sep 9];30:235\u201345. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19952997\/.","DOI":"10.1097\/IAE.0b013e3181bd2c3b"},{"key":"1616_CR65","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0002-9440(10)62993-8","volume":"167","author":"J Miao","year":"2005","unstructured":"Miao J, Xu F, Davis J, Otte-H\u00f6ller I, Verbeek MM, Van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol. 2005;167:505\u201315.","journal-title":"Am J Pathol"},{"key":"1616_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1096\/fj.11-0102ufm","volume":"25","author":"VT Marchesi","year":"2011","unstructured":"Marchesi VT. Alzheimer\u2019s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 2011;25:5\u201313.","journal-title":"FASEB J"},{"key":"1616_CR67","doi-asserted-by":"crossref","unstructured":"Iadecola C. The pathobiology of vascular dementia. Neuron. 2013 [cited 2024 Sep 9];80:844\u201366. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24267647\/.","DOI":"10.1016\/j.neuron.2013.10.008"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01616-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T12:03:41Z","timestamp":1731758621000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01616-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and its informed consent were approved by the Ethics Committee of the Hospital Cl\u00ednic i Provincial de Barcelona in accordance with Spanish biomedical laws (Law 14\/2007, of July 3, on biomedical research; Royal Decree 1716\/2011, of November 18) and followed the recommendations of the declaration of Helsinki. All participants signed an informed consent form (in the case of individuals with moderate stages of dementia, informed consent was signed by their legal representative or family member).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB has consulted for Araclon, Avid, Grifols, Lilly, Nutricia, Roche, Eisai and Servier. She received fees from lectures and funds for research from Araclon, Biogen, Grifols, Nutricia, Roche and Servier. She reports grants\/research funding from Abbvie, Araclon, Biogen Research Limited, Bioiberica, Grifols, Lilly, S.A, Merck Sharp & Dohme, Kyowa Hakko Kirin, Laboratorios Servier, Nutricia SRL, Oryzon Genomics, Piramal Imaging Limited, Roche Pharma SA, and Schwabe Farma Iberica SLU, all outside the submitted work. She has not received personal compensations from these organizations. AR is member of scientific advisory board of Landsteiner Genmed and Grifols SA. AR has stocks of Landsteiner Genmed. MM has consulted for F. Hoffmann-La Roche Ltd. The rest of authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}